Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2014
12/02/2014US8901347 Absorbable polyurethanes and methods of use thereof
12/02/2014US8901341 Amino acid derivatives and absorbable polymers therefrom
12/02/2014US8901277 Interferon alpha mutant and its polyethylene glycol derivative
12/02/2014US8901276 Peptide reagents and methods for detection of colon dysplasia
12/02/2014US8901246 Method for preparing branched functionalized polymers using branched polyol cores
12/02/2014US8901154 High concentration topical insecticides containing pyrethroids
12/02/2014US8901131 Gatifloxacin-containing ophthalmic gel and preparation method thereof
12/02/2014US8901101 Membrane lytic poly(amido amine) polymers for the delivery of oligonucleotides
12/02/2014US8901090 Method of treating otitis externa using macrocyclic lactone compound
12/02/2014US8901075 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
12/02/2014US8901074 Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
12/02/2014US8901072 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
12/02/2014US8901070 Pharmaceutical compositions comprising pore-forming proaerolysin protein (PRX302)
12/02/2014US8901046 Oligonucleotides related to lipid membrane attachment
12/02/2014US8901017 Formaldehyde-free proteinaceous binder compositions
12/02/2014US8900865 Blood brain barrier device
12/02/2014US8900806 Antibody preparations
12/02/2014US8900636 Controlled release compositions
12/02/2014US8900629 Rapidly dissolving pharmaceutical compositions comprising pullulan
12/02/2014US8900623 Sticky soft gel for treating poultry
12/02/2014US8900622 Hypotensive lipid-containing biodegradable intraocular implants and related methods
12/02/2014US8900621 Polyamine derivatives
12/02/2014US8900610 Biocidal fibrous and film materials comprising silver and chlorite ions
12/02/2014US8900606 Methods of applying coating materials for solid medicines
12/02/2014US8900604 Fatty acid conjugates of quetiapine, process for making and using the same
12/02/2014US8900603 Local delivery of drugs from self assembled coatings
12/02/2014US8900602 Disintegrating particle composition and orally rapidly disintegrating tablet
12/02/2014US8900601 Permeable mixtures, methods and compositions for the skin
12/02/2014US8900594 Oral recombinant Helicobacter pylori vaccine and preparing method thereof
12/02/2014US8900592 Protein constructs designed for targeting and lysis of cells
12/02/2014US8900590 Anti-hemagglutinin antibody compositions and methods of use thereof
12/02/2014US8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
12/02/2014US8900577 Immunoglobulin formulation and method of preparation thereof
12/02/2014US8900576 Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
12/02/2014US8900553 Oil and liquid silicone foamable carriers and formulations
12/02/2014US8900551 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
12/02/2014US8900549 Compositions and methods for delivering a substance to a biological target
12/02/2014US8900180 Coatable compositions, coatings derived therefrom and microarrays having such coatings
11/2014
11/27/2014US20140351961 Compositions and methods for treatment of metastatic cancer
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140350493 Dermal delivery device with in situ seal
11/27/2014US20140350453 Bonding tissues and cross-linking proteins with naphthalimide compounds
11/27/2014US20140350452 Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections
11/27/2014US20140350233 Sirna conjugate and preparation method thereof
11/27/2014US20140350228 Use of n-hydroxysuccinimide to improve conjugate stability
11/27/2014US20140350126 New thickening polymer reducing the stickiness of glycerine-based cosmetic formulas
11/27/2014US20140350124 Chain-extended polysiloxane crosslinkers with dangling hydrophilic polymer chains
11/27/2014US20140350120 Topical composition comprising an ingenol derivative and an oily solvent
11/27/2014US20140350118 Topical compositions and methods for making and using same
11/27/2014US20140350106 Urea Silicone Gel for Scars and Hydration Treatment and Method of Using Same
11/27/2014US20140350101 Gel compositions
11/27/2014US20140350094 Solid composition containing catechins
11/27/2014US20140350090 Microrna compounds and methods for modulating mir-122
11/27/2014US20140350085 Novel sugar alcohol-based compositions for delivering nucleic acid-based drugs in vivo and in vitro
11/27/2014US20140350082 PEPTIDE SEQUENCE DESIGN AND USE THEREOF FOR PEPTIDE-MEDIATED siRNA DELIVERY
11/27/2014US20140350063 Biotherapeutics for the treatment of infectious diseases
11/27/2014US20140349979 Stabilized modified release vitamin d formulation and method of administering same
11/27/2014US20140349978 Salicylic Acid Gel
11/27/2014US20140349945 Peg-amino acid-oligopeptide-irinotecan drug conjugates and the pharmaceutical compositions
11/27/2014US20140349944 Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases
11/27/2014US20140349936 Compositions and methods for treating precocious puberty
11/27/2014US20140349933 Self-assembled composite ultrasmall peptide-polymer hydrogels
11/27/2014US20140349930 Treatment using neublastin polypeptides
11/27/2014US20140349929 Multivalent fibronectin based scaffold domain proteins
11/27/2014US20140349928 Peptide pharmaceuticals for insulin resistance
11/27/2014US20140349926 Formulations for the treatment of diabetes
11/27/2014US20140349922 Long-acting glp-1/glucagon receptor agonists
11/27/2014US20140349917 Targeted antimicrobial moieties
11/27/2014US20140348940 Amniotic Membrane Hydrogel and Methods of Making
11/27/2014US20140348933 Mesenchymal precursor cell
11/27/2014US20140348932 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
11/27/2014US20140348930 Omega-3 Fatty Acid Ester Compositions
11/27/2014US20140348929 Omega-3 Fatty Acid Ester Compositions
11/27/2014US20140348926 Formulation and method for increasing oral bioavailability of drugs
11/27/2014US20140348924 Particles comprising single stranded rna and double stranded rna for immunomodulation
11/27/2014US20140348923 Polymeric Drug-Delivery Material, Method For Manufacturing Thereof And Method For Delivery Of A Drug-Delivery Composition
11/27/2014US20140348916 Treatment of Pain with Oral Dosage Forms Comprising Zoledronic Acid and An Enhancer
11/27/2014US20140348906 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes
11/27/2014US20140348905 Gel compositions
11/27/2014US20140348904 Exosomes With Transferrin Peptides
11/27/2014US20140348903 Robust controlled-release formulations
11/27/2014US20140348879 Enteric soft capsules
11/27/2014US20140348876 Stable Aqueous Formulations of Adenovirus Vectors
11/27/2014US20140348860 Medical devices for collecting pathogenic cells
11/27/2014US20140348859 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
11/27/2014US20140348855 Antibody formulations
11/27/2014US20140348852 Method for making precipitated particles
11/27/2014US20140348836 Anti-cd40 antibodies, uses and methods
11/27/2014US20140348817 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
11/27/2014US20140348815 Spray dry method for encapsulation of biological moieties and chemicals in polymers cross-linked by multivalent ions for controlled release applications
11/27/2014US20140348813 Thermostabilization of proteins
11/27/2014US20140348811 Compositions comprising sugar-cysteine products
11/27/2014US20140348810 Absorbable in situ gel-forming system, method of making and use thereof
11/27/2014US20140348789 Targeted mutant alpha-helical bundle cytokines
11/27/2014US20140348787 Methods and Compositions for Treating Ear Infections
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/27/2014US20140348778 Reverse thermal gels and their use in cell therapy
11/27/2014US20140348775 Wound treatment drug for external use
11/27/2014US20140348772 Production of hydrogels by means of diels-alder reaction
11/27/2014US20140348758 Inhalable medicament comprising tiotropium
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 1712